SureTrader SureTrader
Home > Boards > US OTC > Medical - Equipment >

Arrayit Corporation (ARYC)

Add ARYC Price Alert      Hide Sticky   Hide Intro
Moderator: imgoingfishing1
Search This Board:
Last Post: 9/30/2016 12:31:31 PM - Followers: 263 - Board type: Free - Posts Today: 5



Arrayit (ARYC) leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.


- Powerful Science for Life™



Corporate Overview

Arrayit Corporation is a leading life sciences company providing innovative products and services to empower scientists and clinicians to explore the human genome as well as the genomes of plants and animals. Arrayit's worldwide business position leverages the company's widely used patented microarray manufacturing platform and revolutionary VIP™ genotyping technology. Nearly every major research center in the world uses Arrayit products including research laboratories, pharmaceutical companies, universities, biotechnology companies, hospitals, government agencies, and nonprofit research organizations. Novel insights into the function of genes and proteins, early stage disease diagnostics, better and safer medicines, and more nutritional crop plants are some of the many aspects of human health empowered by Arrayit technology.

Corporate Philosophy
Arrayit is an exciting and innovative public company that strives to increase shareholder equity by inventing, developing, manufacturing and supplying sophisticated life sciences products and services to an extensive customer base spanning 50 countries.
Our corporate philosophy is embodied by a highly skilled, multidisciplinary team of investors, business professionals, scientists, engineers and executive and support staff who place shareholder value, product quality, customer service and price competitiveness as our highest priorities. Arrayit empowers decisive strategic advantage and large return on investment for our customers in the research, pharmaceutical, diagnostic, and health care markets.

Corporate History
Arrayit Corporation was founded in 1993 by Rene' Schena and Todd Martinsky as TeleChem International, Inc, a chemical import and export company specializing in plastics, water soluble fertilizers, alternative fuels, and the life sciences. After several years of successful revenues growth, the company expanded in 1999 by adding Dr. Mark Schena and Paul Haje, who together with Ms. Schena and Mr. Martinsky, founded Arrayit Life Sciences, a division of TeleChem International, Inc. Arrayit sought to build on the opportunities created by the deciphering of the human genome and the rise of microarray technology. Arrayit microarrays are sophisticated glass substrates containing large collections of DNA and protein spots that allow all 25,000 human genes and every major protein in the human body to be analyzed in a few hours. Arrayit VIP™ microarrays enable the analysis of the DNA from 100,000 patients in one day. Since 1999, Arrayit has has build a powerful portfolio of patents, trade secrets, and more than 650 life sciences products. The company was featured on the television series
NOVA in 2001, received successive appointments to the Inc. 500 list in 2002 and 2003, and has received numerous local awards including the Rising Star award from the City of Sunnyvale and the Silicon Valley 50 award in 2003. The company changed its name to Arrayit Corporation and began trading on the OTC Bulletin Board in 2009 as ticker symbol ARYC. The company's products and services are used in the life sciences, pharmaceutical, and diagnostics markets, which are estimated at $690 billion in annual revenue.


OvaDx® Ovarian Cancer Diagnostic Test

In Development

Arrayit Diagnostics, Inc. provides the market's first large panel biomarker screening test for ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA approval, Arrayit Diagnostics will offer OvaDx® as an elective test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. OvaDx® will be used by doctors to advance the forefront of ovarian cancer treatment including improved surgical options, more effective chemotherapies, and to supplement existing tests including CA-125, OVA1®, and transvaginal ultrasound.


Diagnostics - Parkinson's Disease

Parkinsons Disease
Arrayit has leveraged the company's patented and proprietary microarray discovery platform to decipher the molecular basis of Parkinson's Disease (PD). This important research project, completed as a collaboration with The Parkinson's Institute (Sunnyvale, California), offers exciting promise for the pre-symptomatic and post-symptomatic diagnosis and treatment of this serious neurodegenerative condition. Arrayit is currently seeking a strategic partner to accelerate FDA approval of the Arrayit PDx™ Parkinson's Disagnostic Test, speed the benchmarking of PDx™ as a companion diagnostic, and determine and enhance the efficacy of pipeline therapeutic proteins and small molecules.


Avant Diagnostics, Inc.

Definitive diagnostic screening test for early stage detection


Avant Diagnostics, Inc., ("AD") previously named Arrayit Diagnostics, Inc., is a Nevada corporation presently a majority-owned subsidiary of Arrayit Corporation ("Arrayit"). AD's business is based upon the completion of the human genome sequencing project. Genetic research is increasingly focused on identifying the variations of the specific genes in the genome. These variations are what define individual characteristics, including disease states or a statistical propensity for disease. The implications are far-reaching and impact not only the research community, but also the individual patients and the medical providers. Diagnostic tests that detect diseases very early in their progression will provide options for earlier treatments that may improve the patient's quality of life and prognosis by delaying or preventing disease progression or even death. Medical providers will incur major cost savings by avoiding costly late stage disease treatments.


© 2013 by Avant Diagnostics, Inc., all rights reserved.

Related Articles
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ARYC News: Current Report Filing (8-k) 04/22/2016 03:59:43 PM
#33004   Essentially more unsubstantiated pie in the sky conjecture!! bgrass1 09/30/16 12:50:11 PM
#33003   First I believe the lawsuit will be dismissed Jeffpacman 09/30/16 12:31:31 PM
#33002   Why have they been waiting for Q4?!! bgrass1 09/30/16 12:09:01 PM
#33001   No, ARYC has been waiting for 4Q. October Jeffpacman 09/30/16 11:14:59 AM
#33000   Mercifully another week of horrendous trading is almost bgrass1 09/30/16 10:01:38 AM
#32998   Wow the triple zero bog pit is now bgrass1 09/29/16 02:11:46 PM
#32997   Very interesting. I wonder if CDEL is doing bgrass1 09/29/16 12:58:18 PM
#32996   NITE naked shorting until kingdom come... joever 09/29/16 12:20:09 PM
#32995   Once again: NO ONE BUYING!!! bhbullish 09/29/16 12:06:43 PM
#32994   Wow could it get any worse for this bgrass1 09/29/16 11:15:40 AM
#32993   Once again: NO ONE SELLING!!! Jimmy Jackson jr 09/29/16 10:41:58 AM
#32992   Wow another miserable day of trading is about bgrass1 09/29/16 09:14:13 AM
#32990   Expert witness and Partial summary Judgment issue have General_Sevier 09/29/16 03:03:34 AM
#32989   I don't take sides!! bgrass1 09/28/16 08:12:56 PM
#32988   Thank you!! I see you are coming Jimmy Jackson jr 09/28/16 06:45:15 PM
#32987   I'm Sorry, I must not have caught that Jeffpacman 09/28/16 03:51:01 PM
#32986   Clearly the plaintiffs -Taub and gang - chose bgrass1 09/28/16 03:26:09 PM
#32985   So why is the bid so stupid? no gmoney20 09/28/16 03:05:25 PM
#32984   ARYC...JEFF...GOOD QUESTION...CAN.ANYBODY.FIND.OUT?? tm1119 09/28/16 12:13:05 PM
#32983   NO ONE SELLING!!!!!!! Jimmy Jackson jr 09/28/16 12:11:58 PM
#32982   It's been five days....would Pacermonitor report the service? "ORDER: Jeffpacman 09/28/16 12:00:00 PM
#32981   Wow 90 minutes into the trading day and bgrass1 09/28/16 11:10:10 AM
#32980   Links?? Jimmy Jackson jr 09/28/16 12:40:51 AM
#32979   You mean the part we all know from General_Sevier 09/28/16 12:36:16 AM
#32978   Here's several: @Arrayit: posted excellent quarterly earnings, Jimmy Jackson jr 09/28/16 12:01:24 AM
#32977   ARYC..AS.I.HAVE.SAID.BEFORE..DO.DD..YOUR.WORDS.."DO.DD.AND.LEARN"..OH..THEY'RE. tm1119 09/27/16 10:54:19 PM
#32976   Link?!! If not it is more pie in the bgrass1 09/27/16 09:25:45 PM
#32975   ARYC...WHERE.HAVE.YOU.BEEN??..DIVIDEND.CAN.NOT.BE.PAID...TAUB..COURT.ORDER.! tm1119 09/27/16 05:58:27 PM
#32974   Nope, Still waiting Danooo 09/27/16 04:41:26 PM
#32973   Anyone get the dividend yet? stockerme 09/27/16 04:24:44 PM
#32972   PPS: no change....OS: no change. AS: no change....hold Jimmy Jackson jr 09/27/16 02:35:08 PM
#32971   Wow wasn't this POS sub penny stinky pinkie bgrass1 09/27/16 01:29:57 PM
#32970   Wow looks like this POS sub penny stinky bgrass1 09/27/16 11:39:47 AM
#32968   Wow less than $150.00 worth of shares traded bgrass1 09/27/16 11:06:57 AM
#32965   It should be $0.000000000000000000000000000000000000000000000012 General_Sevier 09/27/16 10:06:46 AM
#32963   Guess you haven't read a single thing about General_Sevier 09/27/16 09:03:19 AM
#32962   The reason there is no dilution is because bgrass1 09/27/16 08:17:24 AM
#32960   There is no dilution in this stock so Hugie 09/27/16 07:55:01 AM
#32958   The public record indicates its as likely as General_Sevier 09/27/16 12:44:27 AM
#32957   Nothing there that means anything other than the General_Sevier 09/27/16 12:35:15 AM
#32956   Those are from the last 2 business days only.....ARYC Jimmy Jackson jr 09/27/16 12:15:44 AM
#32955   Arrayit new September 21 2016 company newsletter features Jimmy Jackson jr 09/27/16 12:14:45 AM
#32954   Arrayit quotes $128,451 TissueMax Tissue Microarrayer to top Jimmy Jackson jr 09/27/16 12:13:48 AM
#32953   Arrayit reports $20,000 specialty chemical sale to 100% Jimmy Jackson jr 09/27/16 12:12:41 AM
#32952   Arrayit manufacturing team completes custom 2,000 blood card Jimmy Jackson jr 09/27/16 12:11:50 AM
#32951   Arrayit customers in Tel Aviv Israel use Arrayit Jimmy Jackson jr 09/27/16 12:10:46 AM
#32950   Arrayit customers in Toronto Canada use Arrayit microarray Jimmy Jackson jr 09/27/16 12:09:42 AM
#32949   Arrayit completes conference call and site visit with Jimmy Jackson jr 09/27/16 12:08:50 AM
#32948   Arrayit weekend personal instrument inquiries exceed $50,000 on Jimmy Jackson jr 09/27/16 12:07:52 AM